Abstract
In 2002, with the cloning of the (pro)renin receptor (PRR) was given a new vision to prorenin. When the prorenin binds to PRR exhibits catalytic activity and triggers intracellular signaling pathways, resulting finally in a role for the enzyme. These actions may contribute significantly to the development and progression of target organ damage in diabetes and hypertension. Recently, a tra…